Read More Pharma Industry News Could essential tremor finally be entering a new treatment era after Praxis’ Phase 3 results? Praxis Precision Medicines’ Phase 3 results could reshape essential tremor treatment and re-rate the neurology market. Read what this means for investors. bySoujanya RaviApril 15, 2026